(NMR) Nomura Holdings - Overview
Exchange: NYSE •
Country: Japan •
Currency: USD •
Type: Common Stock •
ISIN: US65535H2085
Stock: Investment Banking, Securities Trading, Wealth Management, Asset Management
Total Rating 31
Risk 38
Buy Signal -0.36
| Risk 5d forecast | |
|---|---|
| Volatility | 33.6% |
| Relative Tail Risk | -10.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.76 |
| Alpha | -3.22 |
| Character TTM | |
|---|---|
| Beta | 1.682 |
| Beta Downside | 2.079 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.34% |
| CAGR/Max DD | 1.25 |
EPS (Earnings per Share)
Revenue
Description: NMR Nomura Holdings March 04, 2026
Nomura Holdings, Inc. (NMR) is a Japanese financial services company. It provides investment, financing, and related services globally.
The company operates through three segments. Wealth Management offers investment consultation. Investment Management provides investment solutions, including managing investment trusts and discretionary services. This segment is common among large financial institutions seeking recurring revenue streams. The Wholesale segment handles sales and trading of securities, foreign exchange, and derivatives, alongside investment banking services like underwriting and M&A advisory. Investment banking is a key component of global capital markets, facilitating corporate finance activities.
Nomura Holdings, Inc. was founded in 1925 and is headquartered in Tokyo, Japan. Further research on platforms like ValueRay can provide detailed financial metrics and performance trends.
Headlines to watch out for
- Global market volatility impacts wholesale trading revenue
- Japanese interest rate policy affects wealth management income
- Investment banking deal flow drives advisory fees
- Regulatory changes in financial markets increase compliance costs
- Yen exchange rate fluctuations influence international earnings
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 360.17b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -0.62 > 1.0 |
| NWC/Revenue: 343.4% < 20% (prev -626.6%; Δ 969.9% < -1%) |
| CFO/TA 0.00 > 3% & CFO 264.20b > Net Income 360.17b |
| Net Debt (26015.65b) to EBITDA (529.89b): 49.10 < 3 |
| Current Ratio: 1.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.03b) vs 12m ago -1.11% < -2% |
| Gross Margin: 41.08% > 18% (prev 0.36%; Δ 4071 % > 0.5%) |
| Asset Turnover: 7.16% > 50% (prev 7.62%; Δ -0.46% > 0%) |
| Interest Coverage Ratio: 0.36 > 6 (EBITDA TTM 529.89b / Interest Expense TTM 2581.82b) |
Altman Z'' 1.86
| A: 0.24 (Total Current Assets 50553.49b - Total Current Liabilities 35508.27b) / Total Assets 61935.17b |
| B: 0.03 (Retained Earnings 2067.36b / Total Assets 61935.17b) |
| C: 0.02 (EBIT TTM 920.06b / Avg Total Assets 61232.51b) |
| D: 0.05 (Book Value of Equity 3128.60b / Total Liabilities 58120.58b) |
| Altman-Z'' Score: 1.86 = BBB |
Beneish M -1.65
| DSRI: 3.42 (Receivables 5077.72b/1563.41b, Revenue 4381.60b/4610.26b) |
| GMI: 0.88 (GM 41.08% / 36.16%) |
| AQI: 0.20 (AQ_t 0.18 / AQ_t-1 0.87) |
| SGI: 0.95 (Revenue 4381.60b / 4610.26b) |
| TATA: 0.00 (NI 360.17b - CFO 264.20b) / TA 61935.17b) |
| Beneish M-Score: -1.65 (Cap -4..+1) = CCC |
What is the price of NMR shares?
As of March 10, 2026, the stock is trading at USD 7.76 with a total of 2,922,488 shares traded.
Over the past week, the price has changed by -10.29%, over one month by -16.47%, over three months by -0.26% and over the past year by +30.57%.
Over the past week, the price has changed by -10.29%, over one month by -16.47%, over three months by -0.26% and over the past year by +30.57%.
Is NMR a buy, sell or hold?
Nomura Holdings has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold NMR.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NMR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.8 | 25.6% |
| Analysts Target Price | 9.8 | 25.6% |
NMR Fundamental Data Overview March 05, 2026
Market Cap JPY = 3774.68b (23.91b USD * 157.8629 USD.JPY)
P/E Trailing = 10.8667
P/E Forward = 16.0772
P/S = 0.0117
P/B = 1.0778
P/EG = 0.851
Revenue TTM = 4381.60b JPY
EBIT TTM = 920.06b JPY
EBITDA TTM = 529.89b JPY
Long Term Debt = 15282.76b JPY (from longTermDebt, last quarter)
Short Term Debt = 16729.70b JPY (from shortTermDebt, last quarter)
Debt = 32012.47b JPY (from shortLongTermDebtTotal, last quarter)
Net Debt = 26015.65b JPY (from netDebt column, last quarter)
Enterprise Value = 30881.27b JPY (3774.68b + Debt 32012.47b - CCE 4905.87b)
Interest Coverage Ratio = 0.36 (Ebit TTM 920.06b / Interest Expense TTM 2581.82b)
EV/FCF = -35.55x (Enterprise Value 30881.27b / FCF TTM -868.58b)
FCF Yield = -2.81% (FCF TTM -868.58b / Enterprise Value 30881.27b)
FCF Margin = -19.82% (FCF TTM -868.58b / Revenue TTM 4381.60b)
Net Margin = 8.22% (Net Income TTM 360.17b / Revenue TTM 4381.60b)
Gross Margin = 41.08% ((Revenue TTM 4381.60b - Cost of Revenue TTM 2581.82b) / Revenue TTM)
Gross Margin QoQ = 42.40% (prev 42.03%)
Tobins Q-Ratio = 0.50 (Enterprise Value 30881.27b / Total Assets 61935.17b)
Interest Expense / Debt = 2.11% (Interest Expense 676.17b / Debt 32012.47b)
Taxrate = 30.08% (40.67b / 135.22b)
NOPAT = 643.30b (EBIT 920.06b * (1 - 30.08%))
Current Ratio = 1.42 (Total Current Assets 50553.49b / Total Current Liabilities 35508.27b)
Debt / Equity = 8.77 (Debt 32012.47b / totalStockholderEquity, last quarter 3651.82b)
Debt / EBITDA = 49.10 (Net Debt 26015.65b / EBITDA 529.89b)
Debt / FCF = -29.95 (negative FCF - burning cash) (Net Debt 26015.65b / FCF TTM -868.58b)
Total Stockholder Equity = 3521.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.59% (Net Income 360.17b / Total Assets 61935.17b)
RoE = 10.23% (Net Income TTM 360.17b / Total Stockholder Equity 3521.00b)
RoCE = 4.89% (EBIT 920.06b / Capital Employed (Equity 3521.00b + L.T.Debt 15282.76b))
RoIC = 3.34% (NOPAT 643.30b / Invested Capital 19289.10b)
WACC = 2.60% (E(3774.68b)/V(35787.14b) * Re(12.11%) + D(32012.47b)/V(35787.14b) * Rd(2.11%) * (1-Tc(0.30)))
Discount Rate = 12.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.69%
[DCF] Fair Price = unknown (Cash Flow -868.58b)
EPS Correlation: 50.11 | EPS CAGR: 27.68% | SUE: -0.01 | # QB: 0
Revenue Correlation: 77.80 | Revenue CAGR: 35.19% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.18 | Chg7d=+0.000 | Chg30d=-0.003 | Revisions Net=-1 | Analysts=1
EPS next Year (2027-03-31): EPS=0.78 | Chg7d=+0.000 | Chg30d=+0.028 | Revisions Net=+1 | Growth EPS=-5.7% | Growth Revenue=-1.3%
P/E Trailing = 10.8667
P/E Forward = 16.0772
P/S = 0.0117
P/B = 1.0778
P/EG = 0.851
Revenue TTM = 4381.60b JPY
EBIT TTM = 920.06b JPY
EBITDA TTM = 529.89b JPY
Long Term Debt = 15282.76b JPY (from longTermDebt, last quarter)
Short Term Debt = 16729.70b JPY (from shortTermDebt, last quarter)
Debt = 32012.47b JPY (from shortLongTermDebtTotal, last quarter)
Net Debt = 26015.65b JPY (from netDebt column, last quarter)
Enterprise Value = 30881.27b JPY (3774.68b + Debt 32012.47b - CCE 4905.87b)
Interest Coverage Ratio = 0.36 (Ebit TTM 920.06b / Interest Expense TTM 2581.82b)
EV/FCF = -35.55x (Enterprise Value 30881.27b / FCF TTM -868.58b)
FCF Yield = -2.81% (FCF TTM -868.58b / Enterprise Value 30881.27b)
FCF Margin = -19.82% (FCF TTM -868.58b / Revenue TTM 4381.60b)
Net Margin = 8.22% (Net Income TTM 360.17b / Revenue TTM 4381.60b)
Gross Margin = 41.08% ((Revenue TTM 4381.60b - Cost of Revenue TTM 2581.82b) / Revenue TTM)
Gross Margin QoQ = 42.40% (prev 42.03%)
Tobins Q-Ratio = 0.50 (Enterprise Value 30881.27b / Total Assets 61935.17b)
Interest Expense / Debt = 2.11% (Interest Expense 676.17b / Debt 32012.47b)
Taxrate = 30.08% (40.67b / 135.22b)
NOPAT = 643.30b (EBIT 920.06b * (1 - 30.08%))
Current Ratio = 1.42 (Total Current Assets 50553.49b / Total Current Liabilities 35508.27b)
Debt / Equity = 8.77 (Debt 32012.47b / totalStockholderEquity, last quarter 3651.82b)
Debt / EBITDA = 49.10 (Net Debt 26015.65b / EBITDA 529.89b)
Debt / FCF = -29.95 (negative FCF - burning cash) (Net Debt 26015.65b / FCF TTM -868.58b)
Total Stockholder Equity = 3521.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.59% (Net Income 360.17b / Total Assets 61935.17b)
RoE = 10.23% (Net Income TTM 360.17b / Total Stockholder Equity 3521.00b)
RoCE = 4.89% (EBIT 920.06b / Capital Employed (Equity 3521.00b + L.T.Debt 15282.76b))
RoIC = 3.34% (NOPAT 643.30b / Invested Capital 19289.10b)
WACC = 2.60% (E(3774.68b)/V(35787.14b) * Re(12.11%) + D(32012.47b)/V(35787.14b) * Rd(2.11%) * (1-Tc(0.30)))
Discount Rate = 12.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.69%
[DCF] Fair Price = unknown (Cash Flow -868.58b)
EPS Correlation: 50.11 | EPS CAGR: 27.68% | SUE: -0.01 | # QB: 0
Revenue Correlation: 77.80 | Revenue CAGR: 35.19% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.18 | Chg7d=+0.000 | Chg30d=-0.003 | Revisions Net=-1 | Analysts=1
EPS next Year (2027-03-31): EPS=0.78 | Chg7d=+0.000 | Chg30d=+0.028 | Revisions Net=+1 | Growth EPS=-5.7% | Growth Revenue=-1.3%